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Abstract
The paper is concerned with Fӧrster Resonance Energy Transfer (FRET) considered as a mechanism
for communication between nanodevices. Two solved issues are reported in the paper, namely: signal
generation  and  signal  storage  in  FRET-based  nanonetworks.  First,  luciferase  molecules  as  FRET
transmitters  which  are  able  to  generate  FRET  signals  themselves,  taking  energy  from  chemical
reactions  without  any  external  light  exposure,  are  proposed.  Second,  channelrhodopsins  as  FRET
receivers, as they can convert FRET signals into voltage, are suggested. Further, medical in-body
systems  where  both  molecule  types  might  be  successfully  applied,  are  discussed.  Luciferase-
channelrhodopsin communication is modeled and its performance is numerically validated, reporting
on its throughput, bit error rate, propagation delay and energy consumption. 
1. Introduction
With the current rapid development of technology, electronic and mechanical devices can be much
smaller than even a decade ago, at the same time gaining new operating functionalities. However,
when the device scale goes to the size of single molecules, cooperation between such devices and
contacting  them from outside  their  networks  become quite  challenging  issues.  Fӧrster  Resonance
Energy Transfer (FRET), a phenomenon characterized by very small propagation delays and a good
throughput, has already been proposed for nanocommunications [1] and has been proved to be an
efficient  mechanism  for  transferring  data  at  nanodistances  [2–4].  Research  on  FRET  for
nanocommunication purposes and its integration with other elements on nanoworld is though at an
early stage. 
The main contribution of the paper is solving two issues that, until now, were not solved for FRET-
based  communications  [5].  The  first  issue  is  concerned  with  FRET  signal  storage.  A  molecule
receiving a FRET signal cannot hold it and  the signal  must quickly  be  released, usually emitting a
photon. Here, we propose to use channelrhodopsins which are molecules that can be used as nano-
converters, changing FRET signals into a voltage which can be detected by other devices. The second
issue concerns  FRET signal generation. In FRET nanocommunication experiments so far, a FRET
transmission was initiated by an external laser source, which is rather troublesome inside a human
body. Instead, we propose bioluminescent luciferase molecules as FRET transmitters, which are able
to generate  FRET signals  themselves,  taking energy from chemical  reactions.  We further  discuss
medical  in-body  systems  where  such  FRET-based  communication  between  luciferases  and
channelrhodopsins might be applied. We consider a system of small vesicles, liposomes, circulating
through  human  vascular  system and  collecting  data  about  body  condition.  The  data  gathered  by
liposomes are delivered to a detector placed in a human vein.  Data transmission is  realized by a
luciferase-channelrhodopsin FRET interface.  We model  layers  of  luciferase  and channelrhodopsin
molecules based on their molecular structures and then we use their spectral characteristics to assess
the  efficiency  of  the  FRET communication.  Finally,  we  numerically  validate  the  communication
performance, reporting the bit error rate, throughput, propagation delay and the energy consumption. 
The rest of the paper is organized as follows. In Section 2, we review various mechanisms considered
for nanocommunications. In Section 3, the FRET phenomenon is explained. We present luciferase and
channelrhodopsin  molecules  in  Section 4,  discussing their  properties  and possible  communication
between them. In Section 5, we discuss medical applications where such a communication might be
applied, focusing on data gathering systems based on liposomes. In Section 6, we provide a model for
communication  between  luciferases  and  channelrhodopsins,  while  in  Section  7  we  numerically
evaluate  the  communications  performance.  Finally,  in  Section  8,  we  conclude  the  paper,  also
discussing some open issues. 
2. Molecular communication mechanisms
So  far,  there  has  been  a  number  of  molecular  communication  techniques  proposed  that  can  be
categorized according to their propagation mechanisms. According to [6], the following ones can be
distinguished:  free  diffusion  based  propagation,  flow  assisted  propagation,  active  transport  and
bacteria assisted propagation. This classification can be supplemented with well investigated neural
communication. Transmission parameters, such as delay, throughput and bit error rate (BER), differ
for each of these propagation mechanisms.
Free  diffusion  based  propagation  systems  usually  consist  of  three  main  components:  transmitter,
receiver and signaling molecules that carry information. Signaling molecules freely diffuse over the
liquid medium. In order to send bit ‘1’ the transmitter releases a substantial number of molecules,
while sending bit ‘0’ is done by releasing significantly fewer number of molecules or not releasing
them at all. The performance of this communication method depends on the number of factors such as:
diffusion coefficient, the ratio of signaling molecules representing single bits, size and concentration
of signaling molecules,  rate of molecule release, transmitter–receiver distance and applied detection
rules.  The capacity was estimated to be  in the range between 1 kb/s and 3 kb/s [7] and BER was
reported as near-zero value for distances about few micrometers with energy consumption about 10 -14
– 10-13 J per bit. Diffusion based propagation systems can be enhanced by a flow directed from the
transmitter to the receiver increasing communication range and maintaining BER on the order of 10 -5
[8].
In active transport molecular communication a cargo conveying information molecules is attached on
a transmitter side to a polymer called molecular motor. The molecular motor is able to carry this cargo
and literally walk over a cylindrical molecule called microtubule. The molecular motor walks along a
microtubule until reaches a receiver. Such communication is characterized by a large delay – tens of
seconds and limited range – up to ten micrometers [9]. Near-zero BER can only be achieved for  a
sufficiently long inter  symbol  duration  time  – more  than  a  hundred seconds.  A  slightly different
approach to active transport is presented in [10, 11]: molecular motors are fixed next to each other to a
microtubule, connecting the transmitter and receiver sides. Another shorter microtubule carrying cargo
containing information particles is attached to the molecular motors and propagates along them. The
reported capacity for such a communication channel can reach up to 5 bit/s depending on the number
of information particles.
In bacteria assisted propagation, a bacterium is an information  carrier [12]. Information is stored in
DNA strands that are enclosed in a flagellated bacterium which swims in a liquid environment or over
the tissue surface. By using few hundreds of bacteria an error-free transmission over few millimeters
can be achieved, but at the expense of huge delay, measured in hours.
Neurons  communicate  with  each  other  by  neurotransmitters.  When  a  presynaptic  nerve  cell  is
stimulated,  an  electrical  impulse  called  a  spike  can  be  initiated.  After  the  spike  traverses  the
presynaptic  neuron’s  axon  and  arrives  at  the  axonal  terminal,  it  triggers  the  release  of
neurotransmitters that diffuse to postsynaptic nerve cell to stimulate it. Neural communication was
already studied on the subject of the nerve stimulation frequency, distance between nerve cells [13],
spike width and the number of axonal terminals [14]. It was shown that  the  neural communication
channel capacity can be up to 3000 bit/s (assuming one bit per spike) and the BER can be at level 10 -4
at a distance of few hundreds of micrometers, with energy consumption about 10-16 – 10-13 J per bit.
3. FRET phenomenon for nanocommunications
Fӧrster  Resonance Energy Transfer is  a phenomenon where a signal  may be passed between two
molecules  irradiatively  [15].  Application  of  this  phenomenon  to  nanocommunications  has  been
already proposed and thoroughly investigated [1–3]. In FRET, there is an excited molecule, called
donor,  at  the  transmitter  side,  and  another  molecule,  called  acceptor,  at  the  receiver  side  of  the
communication channel. If the emission spectrum of the donor matches the absorption spectrum of the
acceptor, the excitation energy may pass, without any radiation, from the transmitter, i.e., the donor
molecule, to the receiver, i.e., the acceptor molecule1. The donor and the acceptor must be located very
close to each other, usually of few nanometers, so this is a short range communication mechanism.
FRET has proved to have very small signal propagation delays, on the order of nanoseconds, and a
throughput  of  several  Mbit/s  [4],  and,  therefore,  it  is  very  suitable  for  future  networks  of
nanomachines when cooperating and exchanging information between each other. Recently, routing
techniques  for  FRET-based  nanonetworks  have  also  been  proposed  [5].  The  FRET phenomenon
between a single donor and a single acceptor is not very efficient, as its efficiency decreases with the
sixth power of the donor-acceptor distance r [17]:
E=
R06
r6+R06
, (1)
where  R0 is so called Fӧrster distance, which is a value characterizing the spectral match of donor
emission  and  acceptor  absorption  spectra.  Fӧrster  distance  can  be  obtained  experimentally  or
calculated when the donor and acceptor spectral characteristics are known [17]:
R06=0 . 211⋅ κ
2 nr
− 4 QD∫F D ( λ ) ε A ( λ ) λ4 dλ, (2)
where FD(λ) is the donor emission spectrum with the total intensity normalized to one and εA(λ) is the
acceptor molar extinction coefficient in the function of wavelength, which can be directly derived
1  In some cases, an energy transfer between molecules that are not matched spectrally is also possible; 
see the phenomenon called Phonon-Assisted Energy Transfer [16].
from the acceptor emission spectrum. The integral of the product of these two spectra is called the
overlap integral. QD is the quantum yield of the donor molecule in absence of the acceptor molecule –
this value describes the ratio of emitted photons to absorbed photons, nr is the refractive index which is
assumed to be 1.4 for biomolecules in aqueous solutions and  κ2 is a parameter describing a relative
orientation of donor and acceptor dipoles which is assumed to be equal 0.476 [17], a value appropriate
for the situation when the relative donor-acceptor orientation does not change during the lifetime of
the excited state.
While FRET between single molecules is not efficient, it has been already shown that using multiple
donors and acceptors, in the so called MIMO-FRET communications, FRET efficiency may be quite
high and the transmission bit error rate below 10-3 may be easily reached [3, 4]. Transmission of ‘0’
and ‘1’ bits can be realized with the ON-OFF modulation [18]. While sending bit ‘0’, donors are not
excited, resulting in no energy transfer to acceptors.  It is assumed here that such a transmission is
always  correct  (no  random  excitations  that  could  cause  false  detections),  if  only  a  proper
synchronization is kept between the transmitter and the receiver. When bit ‘1’ is going to be sent, all
donors are excited at the same time. If at least one of them passes its excitation energy to any of the
acceptors, the transmission is successful. With n donors and m acceptors, FRET efficiency is equal to
[4]:
En ,m=1 −(1− m⋅ R06r6+m ⋅R06 )
n
(3)
And the respective bit error rate is given by:
BERn , m=0.5⋅( r6r 6+m⋅R06 )
n
(4)
4. Luciferases and channelrhodopsins
The main contribution of this paper is the proposal of layers of luciferases, at the transmitter side, and
channelrhodopsins, at the receiver side, for FRET-based nanocommunications. Usage of luciferases
may solve the problem of FRET signal generation, as in this case no laser is needed. Instead, the signal
transmission  may  be  initiated  by  a  chemical  reaction.  On  the  other  hand,  application  of
channelrhodopsins will  help with the FRET signal storage.  Channelrhodopsins are able to convert
FRET signals into the electrical voltage. 
4.1. Luciferases
A FRET transmitter, i.e., a donor, in most cases is excited externally, e.g., via a laser beam. In an in-
body medical system, such an approach is yet questionable, as it is the transmitting molecule itself
which should be responsible for initiating the data transmission. In this situation, instead of typical
FRET donors, it is much better to use bioluminescent molecules [19, 20]. For bioluminescent donors,
the source of excitation energy is not external; instead it lies in a biochemical reaction occurring close
to such a molecule2. Thus, the transmitter may be excited by the transmitting nanomachine itself, and
after that, the signal passes to the receiver in the same manner as in typical FRET transmission, i.e.,
without any radiation. 
The bioluminescent donors are, e.g., luciferase molecules [21]. A luciferase is an enzyme that converts
chemical  energy to light  or  FRET signals requiring two other molecule types for the reaction:  a)
luciferins (here, we used furimazine molecules which are a kind of luciferins, 1.5 nm in diameter), and
b) oxygen [22].  The main drawback of  luciferases  is  their  quite long time of relaxation,  as,  e.g.,
NanoLuc luciferase reaction turnover is ca. 3.8 s-1, assuming the ambient temperature about 36 degrees
Celsius [23, 24]. It is, however, not a crucial issue in the case of the considered medical system (see
Section 5), as the system requires sending short messages only, like few bytes of information, about
the human body condition gathered by a liposome particle. 
4.2. Channelrhodopsins
Channelrhodopsins,  containing a retinal  complex inside (see  Fig.  1b),  are  able  to  create naturally
occurring  ion  channels  (pores).  An important  property  of  retinal  is  that,  after  an  excitation,  i.e.,
absorption of a photon or FRET, it opens itself, creating a pore where cations (positive ions present in
human blood, like Ca2+, K+, Na+) may flow through. Such a pore remains open for at least 10 ms [25],
consequently, having in mind typical concentration of cations in human blood of 146 mmol/l, at least
3x104  cations  per  second  flow  through  the  channel  in  that  time  [25].  It  can  be  measured  with
electrodes, as it leads to the potential change behind the layer of channelrhodopsins by 50 mV or
more3 [27].  This channelrhodopsin property means that  such a  molecule  can serve as an  energy-
voltage nano-converter, which is extremely useful for the purpose of receiving FRET signals. 
2  FRET with a bioluminescent donor is also called BRET (Bioluminescent Resonance Energy Transfer).
3  In general, the change of this potential depends on many factors, like cation type and concentration, the 
pool volume, electrodes capacity, etc., and can be calculated with Nernst equation [26]. 
a) b)
Fig. 1. Transmitter (donor) and receiver (acceptor) molecules structures derived from Protein Data Bank and
visualized with Matlab (toolbox Bioinformatics): a) NanoLuc structure 5IBO [28] b) an example of
channelrhodopsin structure 3UG9 [29] with retinal marked in red.
4.3. Luciferase-channelrhodopsin communication
Excitation of a channelrhodopsin may be realized via  a photon and via  FRET as well.  Thus,  the
channelrhodopsins  may  work  as  acceptors  and  receive  FRET  signals  from  luciferase  molecules
working  as  donors  (see  Fig.  2).  The  FRET  efficiency  between  a  single  luciferase  and  a  single
channelrhodopsin is not sufficient for telecommunication purposes and this is why it is proposed to
use large matrices of molecules to communicate, exploiting the MIMO-FRET concept. As explained
in Section 2, sending bit ‘0’ is assumed to be always correct, while successful sending bit ‘1’ requires
that  at  least  one of channelrhodopsins  receives  the  energy from a luciferase.  When the energy is
properly received, channelrhodopsins open their pores, cations from the blood flow through them and
the voltage inside the detector increases. Channelrhodopsins are then inactive for the time of opening
the ion channels.  
Bits ‘0’ may be distinguished from bits ‘1’ by measuring the voltage changes. The energy transfer
between luciferases and channelrhodopsins is  realized via FRET, but  it  may also happen that  the
channelrhodopsin layer catches a photon. These two events should be taken into account together and
the probabilities of both events are considered in the performance analysis reported in Section 6. 
Fig. 2. The luciferase excitation energy may be transmitted to a channelrhodopsin via FRET or a photon.
After being excited and sending a signal, the luciferase molecules have also a period of inactivity,
similarly  as  channelrhodopsins,  but  much  longer.  The  luciferase  turnover  rate  depends  on  the
environmental  conditions  like  temperature  and  substrate  concentration  [30].  If  the  analyzed
communication  system  is  located  inside  a  human  vein,  we  should  take  into  account  the  blood
parameters and its temperature4. Here, we assume NanoLuc luciferases that may be excited once per
0.26 s [23, 24]. This creates a bottleneck for the data transmission and this is why we suggest exciting
simultaneously only a subgroup of all the luciferases when transmitting bit ‘1’. Other luciferases may
be used during the next ‘1’ transmission, increasing the transmission speed, i.e., the throughput of such
a communication channel.  
5. Applications in medical in-body systems
The proposed luciferase-channelrhodopsin communication, based on FRET, looks very promising for
the purpose of future medical in-body systems. Inside a human body, it is rather questionable to use
laser for initiating a FRET transmission and luciferases fueled by a chemical reaction are much more
appropriate. Also, data collection is very straightforward if the FRET signal might be converted into
the electrical one.  Numerous wired detectors [31, 32], which are already used in clinical practice,
might be successfully applied for measuring electrical signals. In this section, we describe an example
of  a  medical  system for  gathering local  data  about  a human body state.  The system is  based on
liposomes circulating in human vascular system. First, we investigate the importance of liposomes in
4  The luciferase turnover rate increases about 2 times per each 10 degrees Celcius of temperature increase
[22].
medical systems. Then, we present a medical system where liposomes collect the data inside human
body and further pass it, via FRET, to a data detector. 
5.1. Medical importance of liposomes
Almost all medical laboratory tests measuring various parameters in human blood reveal the global
compound  concentrations  or  enzyme  activities  in  human  body  without  spatial  distribution  or
differentiation. In most clinical situations, these parameters are even in the whole system and such
result is reliable and gives necessary information. However, in early stages of some disorders, e.g.,
neoplasia, due to its localized process, the global blood parameters are normal. Thus, measuring blood
parameters  do  not  allow proper  identification  of  the  disease.  Local  pathologies  are  diagnosed  in
medicine using various imaging techniques based on X-ray, ultrasound or radioactive nuclides (iodine,
technetium) used in  diagnostic  procedures.  Modern imaging techniques  are  able  to  reveal  objects
smaller than 1 cm in diameter, but are rather not used for screening patients. Also, standard X-ray or
ultrasound techniques are not enough to visualize small tumors. 
The local condition important from the oncological point of view is hypoxia, i.e., insufficient supply
of oxygen  – it may be a hallmark of tumor presence but is also extremely important in the neoplasia
prognosis, i.e., tumors with hypoxia are more aggressive and resistant to therapy [33]. Hypoxia is
caused by abnormalities in the vascular network and is present in majority of malignant tumors [34].
Although there is no correlation between tumor size and hypoxia [33], there are descriptions of highly
hypoxic tumors with less than 1 mm size [35]. Methods for tissue oxygen detection involves several
techniques and can be divided into three groups: direct measurements of oxygen in tissue, evaluation
of  markers  produced by cells  in  response to  hypoxia,  and observation of  physiological  processes
involved  in  oxygen  supply  [33].  It  should  be  emphasized  that  only  few  of  these  techniques  are
approved for clinical use [33], thus the development of new techniques for hypoxia assessment in
patients is required.  One of the possibilities can be usage of biosensors based on liposomes. 
A variety of methods for artificial lipid vesicles (liposomes) formation has been already described
[36]. These methods differ depending on desired properties of the liposomes, i.e., size, the number of
lipid membranes, etc.
The development of biosensors based on lipid membranes or liposome platforms has led to invention
of numerous tools for environment monitoring and clinical diagnostics [36]. The lipid bilayer is the
natural environment for many enzymes, antibodies, and receptors, thus it gives plenty of opportunities
to build a set up for detection of various compounds. Some systems rely only on a lipid membrane
without any incorporated bioelement, i.e.,  a measured molecule is adsorbed into a bilayer causing
biochemical  changes  followed  by  conversion  to  an  electrochemical  signal  (increase  the  trans-
membrane ion current), which is simultaneously amplified [37].
Drugs acting inside cells in some point must go through the lipid membrane. This interaction with the
bilayer may substantially influence drug pharmacokinetics and efficacy [38].  Modern drug delivery
systems are based on polymeric coatings (chitosan or dextrans), which modify lipid-drug interactions
in various ways depending on desired properties and destination of the drug. The special attention is
paid to delivery of reactive plasma species into cancerous cells.  High resolution structural studies
revealed that  synergistic effect  between electric  field fluctuations  and lipid oxidation leads to  the
formation of pores. Through these structures the reactive species pass the lipid bilayer and enter into
the cancer cell [39].
The long term goal of lipid vesicles studies is the development of artificial cells able to substitute
function of damaged or destroyed parts of our organs. The incorporation of artificial components into
a cell-like structure may not only replace the functions of the natural cell [40], but also create features
not met in wild type cells, but desired from the clinical point of view.
5.2. Example of medical data gathering system
Here, we consider liposome particles circulating in human blood and gathering data about the human
body condition and tissues pathology, e.g., tumor occurrence. There is also a wired detector, located in
one of main veins, e.g., the vena cava (either of two main veins delivering deoxygenated blood to the
heart), collecting the data from liposomes (see Fig. 3). 
Fig. 3. The nanocommunication system located in a vein consists of a detector (a thin wire) and liposomes, tiny
vesicles circulating through the human vascular system.
The liposomes work as  mobile  nanosensors.  These particles  have  size  up  to  few micrometers  in
diameter and they circulate in the human vascular system gathering specific data, depending on their
application. At the current level of biotechnology, liposomes may be designed from basic blocks in
laboratories and many components may be added inside and on their surface [41]. Liposomes can be
used for diagnostic and therapeutic applications containing various markers or drugs [42, 43].  Here,
we  assume that  a  layer  of  luciferase  molecules  is  attached to  each  liposome.  A single  luciferase
molecule is of oblong shape, less than 10 nm large, so the layer can be built by placing luciferase
molecules next to each other (Fig. 4). The whole layer, even consisting of hundreds of luciferases, is
very small compared with the liposome, the size of which is on the order of few micrometers. Vesicles
containing furimazine are located under the membrane with luciferase layer, to provide substrates for
luciferase molecule excitations. When a liposome flows through the inferior vena cava close to the
detector, an intermolecular (ligand-receptor, e.g. CD40/CD40L) bond might be created, linking the
luciferases with channelrhodopsin molecules located in the detector [44]. When the bond holds, the
luciferase and the channelrhodopsin layers may be fixed at a deterministic distance from each other,
we  assume  4  nm  here,  thanks  to  the  junction  system  based  on  Annexin-V  molecules  (actually
commercially  available) [45,  46].  After  establishing  the  bond,  the  data  transmission via  FRET is
initiated, what may be realized, for example, using specific proteins called TRAFs [44]. The bond is
kept as long as the data transmission occurs and is released after that via controlling the CD40/CD40L
system. The liposome then returns to circulate through the blood vessels gathering data again. We
assume here that there is a mechanism for attracting the liposome, floating in a vein, close to the
detector.  This  issue is  out  of  the  scope of  this  paper,  but  it  gains  much attention currently,  with
mechanisms like magnetic field or dielectrophoresis (DEP) proposed and thoroughly studied in [47].
 
Fig. 4. The layers of luciferases and channelrhodopsins are bind with intermolecular bonds. 
FRET transmission is initiated, resulting in opening pores for cations.
The detector is a device that can be mechanically put into a human large vein, like inferior vena cava.
Many devices of this type exist and are popular on the medical market; the examples are vein filters
and catheters used for prevention of pulmonary embolism and drug delivery [48]. Here, we assume
that the top of the detector is covered with a layer of channelrhodopsin molecules, which are arranged
in a squared matrix and located on a lipid membrane, using so called black lipid membrane technique
[49, 50]. Above the channelrhodopsin layer (Fig. 4), there are two electrodes to measure the voltage
changes caused by ions entering through channelrhodopsins. 
6. Luciferase-channelrhodopsin communication model 
The  communication  between  the  luciferases  attached  to  a  liposome  (transmitter  side)  and
channelrhodopsins at the detector (receiver side) was further modeled and validated. As explained in
Section 4, information signals may be passed from a luciferase to a channelrhodopsin via FRET or
photon. As both these phenomena are probabilistic ones, computer simulations were conducted. 
First, we modeled both luciferase and channelrhodopsin layers using the molecular structures from
Protein Data Bank (see Fig. 1). A luciferase molecule is 4.6 nm high and its diameter is 2.5 nm; we
assumed having 900 luciferases arranged in a 30×30 square, therefore the size of the layer was 75×75
nm and its thickness was 4.6 nm. On the other hand, a channelrhodopsin molecule is a little larger,
5.35 nm high and 3.2 nm in diameter. The channelrhodopsin layer was planned to be wider than the
luciferase  one,  in  order  to  catch  as  much  FRET and  photon  signals  coming  from luciferases  as
possible. Thus, we had 50×50, i.e. 2500 channelrhodopsins, so the size of this layer was 160×160 nm
and it was 5.35 nm thick. Both layers were very small comparing with the dimensions of a liposome
(1-10 µm) and the detector head (0.5 mm), so they could be easily mounted there. The ligand–receptor
(e.g., CD40/CD40L) connection between the liposome and the detector is needed in order to create a
close  attachment  between  the  luciferase  and  the channelrhodopsin  layers;  the  CD40/CD40L
connection is responsible for creating and disrupting the attachment [44]. 
Second, we modeled FRET communication between the luciferases and channelrhodopsins layers. We
calculated the Fӧrster distance R0 for the luciferase–channelrhodopsin pair as 4.09 nm on the basis of
their spectral characteristics [22, 51] and Eq. (2); see also Fig. 5 for the spectra of luciferase emission
and  channelrhodopsin  absorption.  Each  FRET  transmission  was  considered  separately,  i.e.  we
calculated  the  probability  of  successful  transmission  from  the  donor  molecule  to  the  particular
acceptor molecule in the presence of other acceptors [3]:
Ekl=
( R0rkl )
6
1+ R0
6∑
i=1
m 1
r ki
6
(5)
where  k and  l indicate  the  particular  donor  and  acceptor,  respectively,  and  m is  the  number  of
acceptors.  Only acceptors and donors in ground state were taken into account in the formula.  These
single  probabilities  can  be  summed  over  acceptors  giving  the  total  probability  of  successful
transmission from k-th donor to any acceptor.
Fig. 5. Luciferase emission and channelrhodopsin absorption spectra. 
Third, we also considered a possibility of the acceptor excitation via photon. The probability of hitting
the retinal by a photon was calculated based on simulation of 1 million photon emissions by a single
luciferase. The simulation was performed for each luciferase. We modeled retinal as a circle with the
diameter of 1.35 nm, positioned in the middle of every channelrhodopsin. Direction of the emitted
photon was the result of the composition of vertical and horizontal angles, which were assumed to be
uniformly  distributed.  Keeping  in  mind  that  it  can  happen  only  when  no  FRET  occurred,  the
probability of successful photon transmission between particular donor–acceptor pair can be described
as:
Ekl
' =0.5 ⋅ (1− Ekn ) ⋅ pkl (6)
where  pkl is  the  probability,  obtained  from  the  simulation,  of  the  excitation  of  the  l-th
channelrhodopsin by photon emitted by the  k-th luciferase.  The value  Ekn denotes the probability of
FRET transmission from the  k-th luciferase to all  n donors. The additional factor of 0.5 in Eq. (6)
results from the fact that about 50% of photons hitting the retinal lead to its excitation [52]. Having in
mind the chemical composition of blood, which was the assumed environment, no other quenching
mechanisms were considered.  
Having modeled both probabilities, FRET and photon excitation and adding them to each other, we
finally could calculate the total probability of a successful signal transmission between the luciferase
and channelrhodopsin layers. 
7. System evaluation
Having  models  of  luciferase  and  channelrhodopsin  molecules  and  knowing  the  probabilities  of
successful transmissions, we can evaluate the performance of this communication system. We discuss
it  in the following subsections in respect of the bit  error rate, throughput, propagation delays and
energy consumption.
7.1. Bit error rate
The large layers of luciferases (FRET donors) and channelrhodopsins (FRET acceptors) may be used
to increase the throughput, via parallel transmissions, or reliability, via simultaneous transmissions of
the same bits. As a reference scenario, let us calculate the FRET efficiency in a single luciferase–
channelrhodopsin  communication  using  Eq.  (1).  The  shortest  possible  donor–acceptor  distance  is
equal to the half of the luciferase height plus the length of the ligand receptor bond plus the half of the
channelrhodopsin  height,  which  is  in  total  8.98  nm.  The  Fӧrster  distance  R0  for  the  luciferase–
channelrhodopsin pair is  4.09 nm, so the FRET efficiency is only  0.89%. As explained previously,
there  is  also  a  probability  that  a  photon  emitted  by  the  luciferase  hits  the  retinal  inside  the
channelrhodopsin, but the probability of this event is quite minor and is equal to 0.28%. Thus, the total
probability of a successful signal transmission E1,1 equals to 1.17%. The resulting bit error rate can be
calculated as 0.5(1 –  E1,1) which is  49.42%. Such a value of BER is obviously not acceptable for
communication purposes,  which  is  the  reason to  apply  the MIMO-FRET approach here,  using  a
fraction of  the  total  number  of  luciferases  at  the  same  time  to  transmit  a  single  bit  ‘1’.  As  the
luciferases are characterized by quite a long time of relaxation (remaining inactive 0.26 s after sending
a bit ‘1’), the next bit ‘1’ is transmitted using another, equally numerous group of luciferases. We have
assumed here that  the number  of luciferases  excited when transmitting a bit  ‘1’  is  controlled via
regulation of furimazine (see Sections 4.1 and 5.2) admission, similarly to the mechanism present in
synapses [53].  The furimazine molecules, in a chosen amount, may be packed into small synaptic
vesicles (about 40 nm in size). The release of furimazine from these vesicles is triggered by calcium
ions flux that, in turn, is regulated by electrical impulses that may be generated from the liposome
[53]. Bits ‘0’ are sent just by transmitting nothing, i.e., keeping the luciferases in the ground state, as it
is the ON-OFF modulation. 
We have analyzed 14 scenarios: using 9, 10, 12, 15, 18, 20, 25, 30, 36, 45, 50, 60, 75 and 90 out of the
total number of 900 luciferases to transmit a single bit ‘1’. We have chosen the numbers so they are
divisors of 900; in that way we could use exactly all the luciferases after multiple ‘1’ transmissions.
For each scenario, we have run 100 Monte Carlo simulations with 104 bits (106 bits in total) using the
Matlab computing environment. The bit error rates and the respective 99% confidence intervals for all
the scenarios are shown in Fig.  6.  We can see that using 75 luciferases (8.3%) for a single bit ‘1’
enables to achieve BER below 10-3, while using 90 luciferases (10%) results in BER about 10-4. 
Fig. 6. Bit error rate in the liposome-detector communication as a function of the percentage 
of luciferases active per a single bit ‘1’.
7.2. Throughput
Having more luciferases transmitting the same bit of information increases the diversity, but, at the
same time, decreases the possible communication throughput. As mentioned before, luciferases have
quite a long relaxation period. For the NanoLuc type of luciferases considered in this paper, the total
cycle of their activity may be approximated as 0.52 s in room temperature. Here, the value of 0.26 s is
accepted, as the temperature of human blood is about 10 degrees higher (see Section 4.3). Also, this
value is assumed to be constant, having in mind its very low measured variance [23]. Let us assume
now that 90 luciferases, which makes 10% of their total number, transmit the same bit of information.
After that transmission, these luciferases cannot be used again during 0.26 s, but we can use another
10% of luciferases for the transmission of another bit and so on, and so forth. In total, we can transmit
only 10 bits in 0.26 s, so the throughput is about 38 bit/s. The throughput may be higher when fewer
luciferases are involved in transmission of a single bit,  i.e., the total number of 900 luciferases is
divided  into  more  groups.  In  Table  1,  the  parameters  for  all  14  scenarios  and  the  respective
communication throughput are given. 
As mentioned before, decreasing the number of luciferases transmitting the same bit of information
results  in  a  higher  throughput,  but  a higher BER as  well.  The data from Fig.  6 and Table 1 are
combined together to provide Fig. 7, where the trade-off between the communication throughput and
the diversity is shown. We clearly see that if BER about 10-3 – 10-4 is required, we can achieve the data
transfer rate of 40  –  60 bit/s. This is quite a low value comparing with typical telecommunication
networks;  it  is  also  a  few  orders  of  magnitude  lower  throughput comparing  with  Mbit/s  values
reported [4],  when FRET is initiated with a laser.  This throughput drop is mainly due to the long
relaxation period of luciferases and comes as a price of applying these chemically induced molecules.
However, it should be noted that this throughput is quite sufficient for the purpose of collecting data
from liposomes in the considered medical system. A liposome, performing as a mobile nanosensor,
spends about one minute to make a whole circle through the human vascular system. Spending just
few more seconds when being connected to the detector, the liposome may transmit about 20 bytes
which  is  enough to  pass  the  gathered data.  In  case  of  specific  system requirements,  the  sizes  of
luciferase and channelrhodopsin layers may be adjusted, increased or decreased, if needed.
TABLE 1
THE 14 SCENARIOS CONSIDERED IN THE NUMERICAL EXPERIMENT
Scenario
# of luciferases
transmitting a single
bit
9 10 12 15 18 20 25 30 36 45 50 60 75 90
percentage of total
number of luciferases
[%]
1 1.1 1.3 1.7 2 2.2 2.8 3.3 4 5 5.6 6.7 8.3 10
# of luciferase groups 100 90 75 60 50 45 36 30 25 20 18 15 12 10
respective throughput
[bits/s]
385 346 288 231 192 173 138 115 96 77 69 58 46 38
Fig. 7. Bit error rate in the liposome-detector communication as a function of achieved throughput.
7.3. Propagation delay
In order to assess how fast the signal propagates from a luciferase to a channelrhodopsin, two factors
should be taken into account. The propagation time is very short in both cases of a photon emission
and a FRET.  In the  former,  the  photon travels  with the  speed of  light,  so the  distance of  a  few
nanometers is  reached in a fraction of a femtosecond.  The photon absorption itself  is  a very fast
process as well, also taking less than 10-15 [17]. In the latter, FRET is realized via a dipole-dipole
interaction of a donor and an acceptor, and it  is assumed that its  delay is insignificant. However,
before the energy transfer or the photon emission occurs, the luciferase keeps the energy for a certain
period of time called its excitation lifetime. Its average value is about 5-10 nanoseconds [54], but its
actual value might considerably vary, as this lifetime is given by the exponential distribution. 
7.4. Energy consumption
Finally,  we  can  calculate  the  energy  transferred  and  dissipated  during  data  transmission  in  the
considered system.  The emission energy of a single NanoLuc luciferase (FRET or a photon) can be
assessed, according to the Planck–Einstein relation (energy = Planck constant × frequency, where all
frequencies are averaged over emission intensities), as 3.8  × 10-19 J. Transmitting bit „0‟ costs no
energy, while transmitting bit „1‟ (assuming 10% of luciferases are excited, BER = 10-4, see above)
means exciting 90 luciferases molecules, i.e., costs ca.  3.4 × 10-17 J. Assuming equal number of “0”
and „1‟ bits, we may assess that, on average, during transmission of a single bit, we have 1.7 × 10-17 J
transmitted. Additionally, taking into account the efficiency of the luciferase reaction being about 28%
[23], we have 4.4 × 10-17 J dissipated, so the total energy related to the transmission of a single bit is
about 6.1 × 10-17 J. This energy is lower than in case of other molecular communication mechanisms,
where energy per bit is between 10-16 and 10-13 J (see Section 2).
8. Conclusions and open issues
In this paper, we propose application of two molecule types, luciferases and channelrhodopsins, to
solve the following two important issues in the FRET-based nanocommunications: signal generation
and its storage. Typically, FRET communication is initiated with a laser, but here, we suggest using a
chemical reaction when a luciferase initiates FRET with energy provided by ATP. On the receiver side
of the communication system, we propose channelrhodopsins which can convert FRET signals into
electrical potential. We discuss medical in-body systems designed for gathering data on human body
condition where such FRET-based communication might be very useful. We consider a system with
liposomes circulating in human vascular system and collecting data about local tissue pathologies,
e.g., tumor occurrence. The collected data is further forwarded to a detector, placed into a vein. As
there  is  a  layer  of  luciferases  on  each  liposome  and  the  detector  is  covered  with  a  layer  of
channelrhodopsins,  the  data  transmission  is  realized  via  FRET in  the  luciferase-channelrhodopsin
interface.  The  communication  is  validated  with  numerical  calculations  and  we  provide  the
corresponding throughput, bit error rate, propagation delay and energy consumption. 
Still, there are some aspects of the system which, at the current level of technology, are not solved and
require further studies. The first aspect concerns writing and reading the collected data in a liposome.
Storing data in DNA could be an option and it is currently quite a popular research topic [55]. Data
storage in DNA was recently presented [56]; the main advantage of this solution is its extremely high
efficiency in  terms  of  the  occupied  space:  1.98  bits  per  nucleotide.  The  potential  drawback is  a
relatively low reading rate  compared  to  commonly used  computer  systems.  Additionally,  reading
information stored in DNA needs special enzymes and reaction conditions in vitro. Thus, it is an open
problem  how  to  organize  data  storage  and  reading  in  a  simple  way  suitable  for  the
nanocommunication  system  presented  above.  Moreover,  reading  the  collected  data  should  be
associated with controlling and synchronizing the chemical reaction exciting luciferase molecules , as
it initiates data transmission. Another issue is a mechanism of  attracting liposomes by the detector.
The electric field is rather not a solution, as it might influence other particles in human blood. Instead,
the magnetic field or dielectrophoresis effect might be used [47, 57, 58]. Finally, there is a question
regarding  the  throughput achievable  in  the  liposome–channelrhodopsin  communication.  With
NanoLuc luciferases considered in the paper, the throughput is about 40 bit/s, which is sufficient for
systems focused  on  collecting  medical  data  inside  a  human body.  There  are  still  few options  to
increase the throughput, if needed. First, in some scenarios, the system temperature might be slightly
increased,  what  in  turn  improves  the  luciferase  turnover  rate  [24].  Second,  the  luciferase  and
channelrhodopsin molecules might be carefully positioned in their respective membranes, to keep the
orientations of their dipoles in parallel, increasing in that way the κ2 parameter in Eq. (2) from 0.476
assumed here to even 4 (more than 8 times). Third, the layers of luciferases and channelrhodopsin
might be put even closer than 4 nm from each other; it depends on the Annexin-V molecules used to
mount luciferases on the liposome membrane [46]. If, however, an even higher throughput is required,
one can consider using fluorescent dyes (e.g.,  Alexa, Atto or DyLight)  as donors at the liposome
excited by the light provided by an optical fiber inside the detector. Fluorescent dyes are able to emit
photons or  FRET signals  with  much higher  frequency,  supporting data  throughput  of  Mbit/s  [4].
Nonetheless, in this case, reading the data collected in the liposome should be realized by modulation
of the light coming from the detector, which is a task still not solved.  
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